Bonus Biogroup Stock Price To Earnings To Growth
BONS Stock | ILS 10.80 0.10 0.92% |
Bonus Biogroup fundamentals help investors to digest information that contributes to Bonus Biogroup's financial success or failures. It also enables traders to predict the movement of Bonus Stock. The fundamental analysis module provides a way to measure Bonus Biogroup's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bonus Biogroup stock.
Bonus |
Bonus Biogroup Company Price To Earnings To Growth Analysis
Bonus Biogroup's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
Competition |
Based on the latest financial disclosure, Bonus Biogroup has a Price To Earnings To Growth of 0.0 times. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all Israel stocks average (which is currently at 0.0).
Bonus Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bonus Biogroup's direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bonus Biogroup could also be used in its relative valuation, which is a method of valuing Bonus Biogroup by comparing valuation metrics of similar companies.Bonus Biogroup is currently under evaluation in price to earnings to growth category among its peers.
Bonus Fundamentals
Return On Equity | -0.55 | |||
Return On Asset | -0.0636 | |||
Current Valuation | 169.66 M | |||
Shares Outstanding | 1.17 B | |||
Shares Owned By Insiders | 49.72 % | |||
Shares Owned By Institutions | 0.09 % | |||
Price To Book | 3.39 X | |||
EBITDA | (88.03 M) | |||
Net Income | (90.08 M) | |||
Cash And Equivalents | 3.6 M | |||
Cash Per Share | 0.01 X | |||
Total Debt | 6.28 M | |||
Current Ratio | 0.35 X | |||
Book Value Per Share | 0.12 X | |||
Cash Flow From Operations | (39.84 M) | |||
Earnings Per Share | (0.08) X | |||
Number Of Employees | 13 | |||
Beta | 1.4 | |||
Market Capitalization | 223.15 M | |||
Total Asset | 104.32 M | |||
Z Score | 21.0 | |||
Net Asset | 104.32 M |
About Bonus Biogroup Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bonus Biogroup's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bonus Biogroup using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bonus Biogroup based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Bonus Stock
Bonus Biogroup financial ratios help investors to determine whether Bonus Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bonus with respect to the benefits of owning Bonus Biogroup security.